These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 15554874)

  • 1. Fragmentation and dimerization of copper-loaded prion protein by copper-catalysed oxidation.
    Shiraishi N; Inai Y; Bi W; Nishikimi M
    Biochem J; 2005 Apr; 387(Pt 1):247-55. PubMed ID: 15554874
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carbonyl formation on a copper-bound prion protein fragment, PrP23-98, associated with its dopamine oxidase activity.
    Shiraishi N; Nishikimi M
    FEBS Lett; 2002 Jan; 511(1-3):118-22. PubMed ID: 11821060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prion protein selectively binds copper(II) ions.
    Stöckel J; Safar J; Wallace AC; Cohen FE; Prusiner SB
    Biochemistry; 1998 May; 37(20):7185-93. PubMed ID: 9585530
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Raman spectroscopic study on the copper(II) binding mode of prion octapeptide and its pH dependence.
    Miura T; Hori-i A; Mototani H; Takeuchi H
    Biochemistry; 1999 Aug; 38(35):11560-9. PubMed ID: 10471308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Raman optical activity and circular dichroism reveal dramatic differences in the influence of divalent copper and manganese ions on prion protein folding.
    Zhu F; Davies P; Thompsett AR; Kelly SM; Tranter GE; Hecht L; Isaacs NW; Brown DR; Barron LD
    Biochemistry; 2008 Feb; 47(8):2510-7. PubMed ID: 18205409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Copper reduction by the octapeptide repeat region of prion protein: pH dependence and implications in cellular copper uptake.
    Miura T; Sasaki S; Toyama A; Takeuchi H
    Biochemistry; 2005 Jun; 44(24):8712-20. PubMed ID: 15952778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Products of Cu(II)-catalyzed oxidation of alpha-synuclein fragments containing M1-D2 and H50 residues in the presence of hydrogen peroxide.
    Kowalik-Jankowska T; Rajewska A; Jankowska E; Grzonka Z
    Dalton Trans; 2008 Feb; (6):832-8. PubMed ID: 18239841
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Copper-catalyzed oxidation of the recombinant SHa(29-231) prion protein.
    Requena JR; Groth D; Legname G; Stadtman ER; Prusiner SB; Levine RL
    Proc Natl Acad Sci U S A; 2001 Jun; 98(13):7170-5. PubMed ID: 11404462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interactions of Cu2+ ions with chicken prion tandem repeats.
    Stańczak P; Łuczkowski M; Juszczyk P; Grzonka Z; Kozłowski H
    Dalton Trans; 2004 Jul; (14):2102-7. PubMed ID: 15249945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of the pathological Q212P mutation on human prion protein non-octarepeat copper-binding site.
    D'Angelo P; Della Longa S; Arcovito A; Mancini G; Zitolo A; Chillemi G; Giachin G; Legname G; Benetti F
    Biochemistry; 2012 Aug; 51(31):6068-79. PubMed ID: 22788868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Copper(II) inhibits in vitro conversion of prion protein into amyloid fibrils.
    Bocharova OV; Breydo L; Salnikov VV; Baskakov IV
    Biochemistry; 2005 May; 44(18):6776-87. PubMed ID: 15865423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mass spectrometric determination of the coordination geometry of potential copper(II) surrogates for the mammalian prion protein octarepeat region.
    Pushie MJ; Ross AR; Vogel HJ
    Anal Chem; 2007 Aug; 79(15):5659-67. PubMed ID: 17608450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A reassessment of copper(II) binding in the full-length prion protein.
    Wells MA; Jackson GS; Jones S; Hosszu LL; Craven CJ; Clarke AR; Collinge J; Waltho JP
    Biochem J; 2006 Nov; 399(3):435-44. PubMed ID: 16824036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Membrane interactions and conformational preferences of human and avian prion N-terminal tandem repeats: the role of copper(II) ions, pH, and membrane mimicking environments.
    Di Natale G; Pappalardo G; Milardi D; Sciacca MF; Attanasio F; La Mendola D; Rizzarelli E
    J Phys Chem B; 2010 Nov; 114(43):13830-8. PubMed ID: 20936829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Copper(II) complexes with an avian prion N-terminal region and their potential SOD-like activity.
    La Mendola D; Bonomo RP; Caminati S; Di Natale G; Emmi SS; Hansson O; Maccarrone G; Pappalardo G; Pietropaolo A; Rizzarelli E
    J Inorg Biochem; 2009 Feb; 103(2):195-204. PubMed ID: 19019452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Copper binding to octarepeat peptides of the prion protein monitored by mass spectrometry.
    Whittal RM; Ball HL; Cohen FE; Burlingame AL; Prusiner SB; Baldwin MA
    Protein Sci; 2000 Feb; 9(2):332-43. PubMed ID: 10716185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction of copper(II) with the prion peptide fragment HuPrP(76-114) encompassing four histidyl residues within and outside the octarepeat domain.
    Di Natale G; Osz K; Nagy Z; Sanna D; Micera G; Pappalardo G; Sóvágó I; Rizzarell E
    Inorg Chem; 2009 May; 48(9):4239-50. PubMed ID: 19348438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Products of Cu(II)-catalyzed oxidation of the N-terminal fragments of alpha-synuclein in the presence of hydrogen peroxide.
    Kowalik-Jankowska T; Rajewska A; Jankowska E; Wiśniewska K; Grzonka Z
    J Inorg Biochem; 2006 Oct; 100(10):1623-31. PubMed ID: 16839607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Copper refolding of prion protein.
    Wong BS; Vénien-Bryan C; Williamson RA; Burton DR; Gambetti P; Sy MS; Brown DR; Jones IM
    Biochem Biophys Res Commun; 2000 Oct; 276(3):1217-24. PubMed ID: 11027613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. One octarepeate expansion to the human prion protein alters both the Zn2+ and Cu2+ coordination environments within the octarepeate domain.
    Shearer J; Rosenkoetter KE; Callan PE; Pham C
    Inorg Chem; 2011 Feb; 50(4):1173-5. PubMed ID: 21250682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.